Moving beyond chemotherapy: novel cytostatic agents for malignant mesothelioma
To access this article, please choose from the options below
PII: S0169-5002(04)00183-7
doi:10.1016/j.lungcan.2004.04.022
© 2004 Elsevier Ireland Ltd. All rights reserved.
